Psychiatric comorbidity is common in Crohn ' s disease (CD) and ulcerative colitis (UC). Infl ammatory bowel disease (IBD)-related surgery or hospitalizations represent major events in the natural history of the disease. The objective of this study is to examine whether there is a difference in the risk of psychiatric comorbidity following surgery in CD and UC.
INTRODUCTION
Crohn ' s disease (CD) and ulcerative colitis (UC) are chronic infl ammatory diseases of the gastrointestinal tract aff ecting over 1.4 million Americans and accounting for an estimated $ 6 billion in direct healthcare costs ( 1 -3 ) . Th ey are associated with considerable indirect costs in lost productivity and days absent from work. Nearly two-thirds of the patients with CD require at least one surgery during the course of their disease ( 4, 5 ) , and a signifi cant proportion requires hospitalization ( 4 ) . Up to a third of the patients with UC may require surgical treatment of their Similar Risk of Depression and Anxiety Following Surgery or Hospitalization for Crohn ' s Disease and Ulcerative Colitis
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Incidence of Depression Following IBD-related Surgery disease, either for refractoriness to medical therapy or cancer ( 6 -8 ) . Although recurrence of disease is common aft er surgery for CD, colectomy is considered curative for UC, even though subsequent ileo-anal pouch-related issues including single or recurrent episodes of pouchitis, or other pouch-related complications occur frequently ( 9 ) .
Psychiatric comorbidity, in particular depression and anxiety, are common in patients with infl ammatory bowel disease (IBD). Lifetime prevalence of major depression may approach 30 % and anxiety may occur even more commonly ( 10 -13 ) . Although many cross-sectional or prospective studies have examined the frequency of occurrence of such comorbidity ( 14 -16 ) , fewer have examined risk factors ( 12 ) . Intuitively, disease severity and activity are important determinants of psychological eff ects of an underlying bowel disease ( 11,17 -19 ) . Nevertheless, no prior studies have specifi cally addressed the frequency of occurrence of or risk factors for depression or anxiety following an IBD-related surgery or hospitalization, which represent major events in the natural history of disease. Identifying such subgroups may identify a highrisk cohort of patients who could be targeted for screening for such comorbidity and may also identify early interventions to improve outcomes. Furthermore, no studies have specifi cally compared the occurrence of such psychiatric comorbidity following surgery or hospitalization between CD and UC.
We performed this study with the aims of (1) examining the risk of depression and anxiety following an IBD-related surgery or hospitalization in a large multi-institution cohort; (2) identifying the risk factors for such psychiatric comorbidity following surgery or hospitalization in IBD patients; and (3) comparing the occurrence of such psychiatric comorbidity in those patients with CD with that of UC patients undergoing interventions.
METHODS

Study cohort
Th is study included a cohort of patients with CD or UC seen at two large tertiary referral hospitals (Massachusetts General Hospital, and Brigham and Women ' s Hospital) in Boston, serving over four million people. Prior work has described the creation of this cohort in detail ( 20 ) . In brief, we fi rst extracted all patients with ≥ 1 International Classifi cation of Diseases, 9th Edition (ICD-9) code for CD (555; n = 14,288) or UC (556; n = 14,355). Subsequently, using an algorithm developed using clinical, laboratory, endoscopy, and pathology data, refi ned using ICD-9 codes and free-text natural language-processing concepts, we identifi ed a cohort of 5,506 CD and 5,522 UC patients with a positive predictive value of 97 % , with validation of the algorithm through additional chart review by a board-certifi ed gastroenterologist ( 20 ) .
Variables
Information was obtained on age, age at the time of the fi rst diagnosis code of CD or UC, gender, and modifi ed Charlson comorbidity index ( 21 ) (excluding variables related to anxiety or depression), using the ICD-9 codes. We identifi ed the cohort of patients who underwent a bowel resection through the use of ICD-9 codes for abdominal surgery ( Supplementary Table 1 ) , and extracted the date of the occurrence of such procedures. Information was also obtained on disease-related complications, including fi stulizing or stricturing disease, and perianal disease for CD patients, using the ICD-9 codes ( Supplementary Table 1 ). Use of medications, including immunomodulators (azathioprine, 6-mercaptopurine, methotrexate), antitumor necrosis factor-α therapies (infl iximab, adalimumab), and corticosteroids (prednisone, budesonide), were ascertained as codifi ed data using the electronic prescription function of our electronic medical record. Th e IBDrelated hospitalizations were identifi ed as those with a primary diagnosis of CD or UC upon discharge from the hospital. We also identifi ed patients who had undergone at least one stoma surgery (ICD-9 46.1, 46.2) and those who had undergone more than one surgery. To adjust for intensity of healthcare utilization, we included a variable -" number of facts " -which included the total number of distinct medical encounters, including offi ce visits, laboratory tests, radiological studies, and inpatient or outpatient procedures. Th is, divided by the duration of follow-up, yielded a " fact density, " which was a measure of healthcare utilization per unit time of follow-up.
Outcomes
Our primary outcome of the study was the development of anxiety and depression defi ned as in previous studies, using the ICD-9 codes for depressive disorders (296.2, 296.3, 298.0, 311) or generalized anxiety (293.84, 300.0, 313.0) ( 13, 22 ) . To validate the accuracy of the ICD-9 codes for depression and anxiety, we selected a random subset of 100 patients from both hospitals with each of these codes, reviewed their medical records, and found a positive predictive value for a diagnosis of depression or anxiety to be 92 % and 90 % , respectively. Th e predictive value was similar from both major hospitals (Massachusetts General Hospital and Brigham and Women ' s Hospital). Patients who had a diagnosis code for depression or anxiety before or on their fi rst date of surgery, or within 30 days aft er the date of surgery were excluded from this study, to reduce likelihood of identifying prevalent cases ( Figure 1 ). Similarly, in the analysis of hospitalizations, those with psychiatric comorbidity (major depression or anxiety) at the time of or before an IBD-related hospitalization, or within 30 days of such a hospitalization, were excluded.
Statistical analysis
All data were analyzed using Stata 11.0. (StataCorp, College Station, TX, USA). Continuous variables were summarized using means and s.d. and compared using Student ' s t -tests. Categorical variables were expressed as proportions and compared using the χ 2 -test. Multivariate logistic regression analysis adjusting for potential confounders formed our main analysis examining predictors of depression or anxiety following surgery or hospitalization. Variables were selected for entry into the multivariate model based on signifi cance at P < 0.1 on univariate analysis. Th e multivariate analysis was carried out using the forward stepwise procedure, retaining variables with P < 0.05. To account for secular trends in coding, year of surgery was included as a separate variable in all our multivariate models. We examined the occurrence
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of such psychiatric comorbidity in the entire CD / UC cohort, as well as each disease subgroup individually, comparing the rates across CD and UC. Th e predictors of depression and anxiety were also examined in the overall cohort, as well as CD and UC separately. We performed sensitivity analyses to examine if having the diagnosis code for post-surgery depression or anxiety was a refl ection of frequency of healthcare utilization by adjusting for fact density as described above, and for frequency of outpatient visits. Th e study was approved by the Institutional Review Board of Partners Healthcare.
RESULTS
Study population
Th ere were a total of 744 CD and 556 UC patients in our cohort, who underwent ≥ 1 bowel resection surgery and did not have a diagnosis of depression before surgery. Among these, 63 patients had their fi rst diagnosis code for depression within 30 days of the surgery (median 1 day) and were excluded, resulting in 707 CD and 530 UC patients who were included in the analysis of postsurgery depression ( Figure 1 ). Th e mean age of the cohort was 48 years, with a mean age at surgery of 42 years. Just under half the cohort were women (47 % ). Th e cohort for analysis of anxiety following an IBD-related surgery comprised 1,183 patients.
Risk of depression and anxiety following IBD-related surgery or hospitalization
A total of 128 CD patients subsequently were given a diagnosis code for depression at a median of 2.2 years. Among those who required surgery, the risk of depression at 1, 2, and 5 years aft er surgery was 6 % , 8 % , and 16 % , respectively ( Figure 2 ). Similarly, 54 UC patients were given a diagnosis of depression at a median of 2.5 years. Interestingly, the risk of depression at 1, 2, and 5 years aft er surgery for UC was similar to the CD cohort at 5 % , 7 % and 11 % , respectively ( Figure 2 ). Th e crude overall frequency of depression was higher than what we found for those undergoing surgery for diverticulitis (9 % ) or inguinal hernia (7 % , P < 0.05). On multivariate logistic regression, adjusting for age, gender, and comorbidity, there was no diff erence in the risk of depression among the post-surgery CD and UC patients (adjusted odds ratio (OR), 1.11; 95 % confi dence interval (CI), 0.84 -1.47), suggesting a similar risk of post-surgery depression in both diseases. Among the entire CD cohort, 4,762 patients never required surgery. Compared with such patients, we observed a signifi cantly elevated risk of depression in patients who required surgery (adjusted OR, Th e risk of anxiety following IBD-related surgery at 1, 2, and 5 years was 7 % , 9 % , and 14 % , respectively, in CD patients and 7 % , 10 % , and 12 % , respectively, in UC patients. Th ere was no diff erence in the likelihood of anxiety based on IBD type (OR for CD vs. UC, 1.09; 95 % CI, 0.82 -1. 44 ). Unlike what we identifi ed for depression, the likelihood of anxiety following an IBD-related surgery was only mildly elevated compared with those who never underwent surgery for either CD (OR, 1.20; 95 % CI, 0.93 -1.55) or UC (OR, 1.26; 95 % CI, 0.96 -1.65).
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A total of 2,062 CD patients and 1,345 UC patients required at least one IBD-related hospitalization, among whom 33 and 41 % subsequently required surgery. An IBD-related hospitalization itself was associated with a signifi cant risk of depression. Even excluding those who subsequently underwent surgery, the risk of depression 5 years aft er a CD-related hospitalization was 17 % , with a corresponding risk of anxiety of 12 % . Th is was nearly twofold the risk of depression in those who never required hospitalization (OR, 1.91; 95 % CI, 1.60 -2.77). Similarly for UC patients, a disease-related hospitalization was associated with an increase in risk for depression (OR, 1.28; 95 % CI, 1.06 -1.54) and anxiety (OR, 1.32; 95 % CI, 1.09 -1.59) compared to those who were never hospitalized. Table 1 presents the characteristics of the patients, stratifi ed by disease type and depression status. Both UC and CD patients who developed depression following surgery were more likely to be female and had greater comorbidity. However, there were also differences between the two diseases. In CD, depressed patients were also more likely to be younger than 35 years at the time of surgery, or had surgery within 3 years of fi rst diagnosis code for CD. Th e only disease phenotype associated with depression was the presence of perianal disease, which was nearly twice as common in those with depression as those without. Th ose who developed depression were signifi cantly more likely to have required a stoma than those without (27 % vs. 15 % ). Th e risk of depression 5 years aft er stoma surgery was 31 % compared with 19 % in those who never underwent stoma surgery ( Figure 3 ) . In UC patients, early surgery within 3 years was associated with an increased risk for depression similar to that seen for CD. However, there was no difference by age at surgery. Interestingly, there was also diff erence in risk of depression by requirement of a stoma in UC patients, likely because of the high frequency of requiring a stoma (temporary or Multivariate analysis for predictors of anxiety revealed a signifi cant overlap with the risk factors for depression, with similar eff ect sizes for nearly all parameters for both CD and UC ( Table 3 ) .
Predictors of depression and anxiety following IBD-related surgery
Sensitivity analysis
We performed a variety of sensitivity analysis to examine the robustness of our fi ndings. Primarily, to determine if the increased risk of anxiety or depression following surgery was solely a refl ection of increased healthcare utilization (and consequently, increase in the number of diagnosis codes) in such patients, we adjusted for the number of outpatient gastroenterology offi ce visit, all outpatient visits with a diagnosis of CD or UC, and number of inpatient hospitalizations, and found no attenuation of our eff ect sizes. Similarly, our OR estimates were rendered larger, adjusting for density of healthcare utilization.
DISCUSSION
Th ere is an increased risk of depression and anxiety in patients with CD or UC ( 10 -13 ). Th e extent to which this increased risk is determined by severity of disease is unclear. Furthermore, there permanent) as part of a two-or three-stage total colectomy with ileo-anal pouch reconstruction. As there were diff erences in risk factors, we performed separate stepwise multivariate logistic regression analyses for both diseases. In CD, the strongest predictor was non-IBD medical comorbidity ( Table 2 ). Having a stoma was the next strongest predictor with an OR of 1.90 (95 % CI, 1.15 -3.13). Female gender, perianal disease, need for immunomodulator therapy, and early surgery within 3 years also moderately increased the risk of depression following surgery. Th e risk of depression increased with the number of risk factors; only 8 % of those with 0 or 1 risk factor subsequently developed depression compared with 20 % of those with 2 or 3 risk factors, and 44 % of those with 4 or more risk factors ( Figure 4 ) . However, the distribution of risk factors was also not uniform between the risk strata; only 2 % of those in the lowest risk category had a stoma surgery compared with 46 % of the highest risk stratum. On the other hand, for UC, only female gender (OR, 2.92) and Charlson score ≥ 3 (OR, 3.73) were associated with increased risk of depression ( Table 2 ). All risk factors retained in the multivariate analysis by stepwise regression are described in the table. 
INFLAMMATORY BOWEL DISEASE
Incidence of Depression Following IBD-related Surgery
have been no prior studies that have quantifi ed the risk of such psychiatric comorbidity aft er the IBD-related surgery or hospitalization, which represent major events in the natural history of IBD. Using a multi-institutional cohort, we demonstrate that even aft er excluding those who received a diagnosis of depression before surgery, CD and UC patients who underwent an IBD-related surgery had a 16 % and 11 % risk of receiving a diagnosis of depression at 5 years, with a similar substantial risk of anxiety. Furthermore, despite surgery for UC being considered curative, we observed a similar risk between both diseases. We also identifi ed several subgroups of patients at higher risk of such comorbidity, which may facilitate targeted screening and early intervention.
Several studies have examined the co-occurrence of psychiatric comorbidity in patients with IBD ( 13 -16,23 ) . However, there is limited literature examining risk factors for psychological distress in patients with IBD. Nahon et al. ( 12 ) administered a questionnaire to 1,663 patients with IBD and identifi ed 11 % of the patients to be depressed and 41 % to be anxious. On multivariate analysis, severity of disease defi ned as requiring two or more courses of steroids, hospitalization, and need for immunosuppressive therapy or intestinal resection was an independent risk factor for anxiety but not depression. However, this broad defi nition of severe disease resulted in nearly 90 % of their cohort, irrespective of psychiatric comorbidity, being classifi ed as having severe disease, limiting the utility of such composite defi nitions. Indeed when restricting their analysis to individual components of disease severity, they found that past history of surgery was associated with a lower risk of anxiety and had no eff ect on risk of depression. Our study diff ers from the prior studies in that we specifi cally focused on a relatively homogenous cohort of CD or UC patients who had all undergone surgery or required hospitalization. By specifi cally excluding those who received a diagnosis of depression or anxiety before surgery, we attempted to minimize the number of prevalent cases and the possibility of reverse causation or confounding, where disease activity predicts both surgery as well as occurrence of psychiatric comorbidity.
A key and interesting fi nding from our study is that the risk of depression or anxiety following IBD-related surgery or hospitalization was similar in CD and UC. Although surgery for CD is usually not curative, is followed by nearly universal disease recurrence with only mild attenuation of this risk with existing medical therapies, a total colectomy for UC is considered curative. Th ere are a few possible reasons for persistence of the risk for depression and anxiety in UC patients following surgery, similar to that for CD. First, even aft er an ileal-pouch, patients can continue to be have frequency of bowel movements, including need for nocturnal bowel movements, which could aff ect health-related quality of life, which could in-turn lead to depressive symptoms ( 24 ) . Second, up to half of the patients may have at least one episode of pouchitis, whereas one-quarter may have recurrent episodes ( 9 ) . Such fl uctuations in disease activity could also infl uence risk of depression or anxiety. Th is is consistent with the fi ndings from a small study by Hauser et al. ( 25 ) that patients with an ileal pouch-anal anastomosis did not diff er in their risk of depression compared with UC patients without ileal pouch-anal anastomosis, but were more likely to be depressed than the general population. Other studies have similarly shown that patients with an ileal pouch-anal anastomosis continue to have impairment in quality of life compared with the general population ( 26, 27 ) , although the literature in this area has yielded confl icting results ( 28 ) .
We also identifi ed common and distinct risk factors for depression following IBD-related surgery. Female gender was common across both diseases, consistent with prior studies examining health-related quality of life and psychiatric comorbidity in IBD ( 29 -32 ) . In a prospective study, Beaugerie et al. ( 33 ) demonstrated that perianal disease was associated with a disabling course of CD. A high proportion of patients with perianal CD have depressive symptoms ( 34 ) and demonstrate long-term impairment of quality of life ( 35 ) . In addition, early surgery defi ned as undergoing a resection within 3 years of fi rst CD diagnosis code in our health system also increased the risk of depression post-operatively, consistent with the hypothesis associating aggressive disease behavior with psychological comorbidity.
Requiring an ostomy bag is one of the highest rated concerns among CD and UC patients ( 36 -38 ) . In the present study, among CD patients the risk of depression or anxiety was infl uenced quite strongly by having an ostomy, which was the strongest risk factor aft er non-IBD comorbidity. However, we found no such eff ect on UC patients, which could be due to the high frequency of stoma procedures (as part of two-or three-stage colectomy surgeries in UC patients). Th e literature on the eff ect of stoma on risk of subsequent psychological comorbidity has been inconsistent. Aft er surgery for colorectal cancer, having a stoma is associated with worse body image ( 39 ) and increases risk for anxiety or depression. However, in CD, where surgery may not represent a permanent cure from disease, and patients may continue to experience symptoms related to ongoing bowel or perianal disease, having a stoma has not been consistently associated with worse quality of life when compared with other CD controls ( 35, 40 ) . However, no prior studies have specifi cally examined the eff ect of stoma or multiple surgeries on post-operative anxiety or depression in an IBD cohort. All risk factors retained in the multivariate analysis by stepwise regression are described in the table.
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In conclusion, we demonstrate that IBD-related surgery or hospitalization is associated with a signifi cant risk for depression and anxiety in both CD and UC patients with similar magnitudes of risk across both diseases. Female gender and non-IBD comorbidity were common risk factors for depression or anxiety in both CD and UC. Requirement for a stoma was a strong risk factor for depression following surgery in CD patients, but not UC patients. Continued screening for psychiatric comorbidity following IBDrelated surgery or hospitalization should be part of comprehensive IBD care, particularly for high-risk patients. Th ere is need for ongoing research into eff ective modalities to improve healthrelated quality of life and other outcomes in such patients.
In addition, the association with non-IBD comorbidity suggests that such patients may be more susceptible to functional impairment and consequences of IBD-related surgery or hospitalization. Th e association between comorbidity and increased healthcare utilization post-operatively has also been demonstrated in other cohorts ( 41, 42 ) , suggesting management of IBD patients with such comorbidity, particularly in the setting of severe disease requiring surgery remains challenging.
Finally, another important fi nding from out study was that an IBD-related hospitalization, even in the absence of subsequent surgery, was associated with a signifi cant risk for depression and anxiety. Th is demonstrates that in addition to their eff ect on healthcare costs, hospitalizations remain an important event in disease course of both CD and UC. As demonstrated by prior studies, those requiring hospitalization form a high-risk cohort for subsequent surgery ( 4, 43, 44 ) , but even in the absence of such an eventuality, they remain at risk for psychological comorbidity associated with their disease. Consideration must be given for routine screening for depression and anxiety in this cohort as well.
Our study has several implications. To our knowledge, ours is the fi rst study specifi cally examining the overall occurrence of depression and anxiety following IBD-related surgery or hospitalization, as well as the comparative incidence between both diseases. Our examination of predictors of depression or anxiety suggest that there are strong demographic-, disease-, or surgery-related characteristics that place a patient at a substantially elevated risk of psychological comorbidity even among a cohort with relative homogeneity in their disease severity. We suggest the need to routinely screen such patients for depression and anxiety as part of standard care in the immediate and late post-operative period, as well as aft er an IBD-related hospitalization. Given the signifi cant morbidity and healthcare utilization associated with psychiatric comorbidity, there is need for continued research into eff ective interventions to identify and treat such patients, and whether preventive interventions may be warranted in high-risk patients.
Th ere are a few limitations to our study. First, we relied on administrative coding to identify the presence and date of diagnosis of depression or anxiety in the post-operative setting, as well as predictors, which may result in misclassifi cation. However, misclassifi cation is unlikely to be diff erential between the various risk factors, and we performed a validation of the ICD-9 codes used. Recognizing the increased risk for depression and anxiety, future prospective studies are necessary with structured evaluation of mood and other psychiatric comorbidity following IBD-related surgery or hospitalization. Second, we did not have accurate and comprehensive information on the use of antidepressant or antianxiety medications in our cohort. Th ird, owing to the referral nature of our institutions, further studies examining our hypothesis in a population-based cohort will help confi rm the generalizability of our results. Given the linear increase in depression and anxiety diagnosis over time, it is unlikely that our fi ndings are solely due to increased frequency of healthcare utilization and, thus, the number of diagnosis codes, in the immediate perioperative period. We also did not have information on smoking status, which could infl uence risk of surgery in CD.
